Search results
Physicist Studying SARS-CoV-2 Virus Believes He Has Found Hints We Are Living In A Simulation
IFLScience· 6 days agoA physicist studying mutations of the SARS-CoV-2 virus claims to have found evidence for a new law...
Lungs of young adults more susceptible to SARS-CoV-2 virus: Study
Investing.com· 6 days agoLungs of young adults more susceptible to SARS-CoV-2 virus: Study
Newly Discovered Prehistoric Snake May Be Largest To Ever Exist, Vaccine Breakthrough Could Mean...
IFLScience· 3 days agoThis week, a physicist studying the SARS-CoV-2 virus believes he’s found evidence that we’re living...
Advanced RNA Sequencing Reveals the Drivers of New COVID Variants
SciTechDaily· 1 day agoThe SARS-CoV-2 virus that causes COVID has the unsettling ability of often generating variants of...
Optimal timing maximizes Paxlovid benefits for treating COVID-19
Medical Xpress· 49 minutes agoResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife ...
UK virtually ends free vaccines as COVID-19 continues to spread
World Socialist Web Site· 2 days agoConsequently, the SARS-COV-2 virus still infects tens of thousands weekly, leading to hundreds of...
WHO clarifies terminology for air-transmitted pathogens
Medical Xpress· 5 days agoDuring the COVID-19 crisis the standoff between experts arguing over whether the SARS-CoV-2 virus...
Xencor (NASDAQ:XNCR) Price Target Cut to $38.00
ETF DAILY NEWS· 6 days agoXencor (NASDAQ:XNCR – Get Free Report) had its target price lowered by analysts at BTIG Research from $56.00 to $38.00 in a research report issued to clients and investors on Tuesday, MarketBeat.com ...
COVID virus mutated in Dutch man, raising importance of proper immunocompromised care
Cosmos· 4 days agoForthcoming research from the group relates to a previously reported case of a 72-year-old Dutch man who was infected with the SARS-CoV-2
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National...
Digital Journal· 1 day agoModerna has generated preclinical and clinical data of its monovalent XBB.1.5 vaccine candidate showing an immune response against XBB sublineages and currently circulating strains of the < ...